I tried logs, boxes, buckets, garden beds, and an automated fruiting chamber to grow my own mushrooms. Two methods emerged ...

Apollo funds and ⁠affiliates would take a minority, non-controlling stake in a new entity holding the LARC business, while Bayer keeps a majority stake and "complete operational control." Sign up here ...

Discover powerful machines designed to remove fallen trees quickly and efficiently making forestry work and storm cleanup safer faster and more productive with advanced equipment built for demanding ...

Hyderabad: To ensure safer, faster and environmentally friendly tree trimming operations near power lines, TGSPDCL has introduced advanced battery-powered professional tree pruners into its field ...

Wall Street's major indexes ended lower on Friday as the technology sector continued its selloff after mounting concerns over elevated AI-related valuations and OpenAI considering pausing its IPO ...

Collaboration focuses on small molecule discovery Bayer to leverage Iambic’s AI platform to address hard-to-drug targets Collaboration will strengthen Bayer’s research and development portfolio by ...

Phase II ARACOG (AFT-47) head-to-head trial met its primary endpoint, with patients treated with NUBEQA® (darolutamide) showing a decline in maximally changed cognitive domain (MCCD) by 24 weeks, with ...

Primary results from the Phase II ARACOG (AFT-47) trial, a head-to-head randomized trial conducted by Alliance Foundation Trials LLC, showed that patients treated with NUBEQA ® (darolutamide; n=55) ...

Less than 48 hours after Crystal Palace’s UEFA Conference League triumph, Bayer Leverkusen will hold a meeting with Oliver Glasner as their search for a new head coach continues. It comes after die ...

“Secondary stroke remains a serious and persistent challenge, and the FDA’s Priority Review designation underscores the urgency of advancing potential new approaches in secondary stroke prevention,” ...

Bayer has removed a protein therapeutic for hypertension and a treatment for diabetic neuropathic pain from its phase 1 pipeline. The German pharma giant had already evaluated an atrial natriuretic ...